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Outpatient Antibiotic Use and
Antibiotic Resistance
Antibiotic resistance is an important
public health concern [1]. Antibiotics are
one of the most commonly prescribed
drug classes worldwide, with considerable
variation in outpatient antibiotic use
between countries [2]. Viral respiratory
tract infections drive antibiotic overpre-
scribing in the outpatient setting, and this
overprescribing is also influenced by
patient demand and expectations [3,4].
There has been great interest in the
public health community in avoiding
unnecessary prescriptions, not only by
providing treatment guidelines and deci-
sion support to physicians, but also by
educating the public about appropriate
antibiotic use. But the most effective
strategy to achieve this goal remains
unknown [5]. In the 1990s, one of the
first national campaigns to reduce anti-
biotic prescribing resulted in a decrease
in antibiotic use and penicillin-resistant
Streptococcus pneumoniae in Iceland [6].
Since that time, there have been many
other public campaigns, but published
data about their impact remain scarce.
Until now, the best evidence correlating a
national campaign to a reduction in
antibiotic use came from Belgium, where
yearly mass media campaigns were asso-
ciated with a 36% reduction in antibiotic
prescriptions between 1999–2000 and
2006–2007 [7].
The French National Campaign
To Reduce Unnecessary
Antibiotic Use
In a new study published in this issue of
PLoS Medicine, Didier Guillemot and col-
leagues analyze the impact of a similar
campaign in France, which used to be
known for the highest rates of antibiotic
use and pneumococcal resistance in Eur-
ope [8,9]. In 2001, French policy makers
and public health authorities launched a
coordinated and multifaceted strategy for
the control of antimicrobial resistance.
One of the key interventions was a yearly
campaign targeting the public via mass
media, conveying the message that ‘‘Antibi-
oticsAre NotAutomatic’’ (especiallyfor viral
respiratory tract infections). Simultaneously,
the streptococcal rapid antigen test and
treatment guidelines were promoted among
health care professionals. A substantial
number of primary care physicians were
targeted by one-on-one educational sessions
known as ‘‘academic detailing’’.
Analyzing prescribing data provided by
the national health insurance (covering
over 90% of the population) for two
winters before and five winters after the
launch of the first campaign, Guillemot
and colleagues observed a decline by
26.5% in the number of antibiotic prescrip-
tions, surpassing even the national target of a
25% reduction over five years.The decrease
w a ss e e ni na l lF r e n c hr e g i o n sa n da g e
groups,withthehighestdecreaseobservedin
children. Despite this decline in antibiotic
use,arelativeincreaseinfluoroquinoloneuse
by 12.8% was observed, indicating the
possibility that the choice of antibiotic may
have become less appropriate for certain
treatment indications.
Strengths and Limitations of
the Study
This study provides the largest and most
sophisticated analysis published thus far
correlating a nationwide public campaign
to decreased antibiotic use over an ex-
tended period of time. The researchers
address many potential sources of bias and
confounding [10].
Nevertheless, some issues warrant fur-
ther comment. Although it is likely that the
reduction in antibiotic prescribing was
causally related to the campaign, the
ecological before-and-after study design
cannot provide definitive proof of causal-
ity. As mentioned by the authors, in a few
European countries a decrease in antibi-
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Linked Research Article
This Perspective discusses the fol-
lowing new study published in PLoS
Medicine:
Sabuncu E, David J, Berne `de-Bau-
duin C, Pe ´pin S, Leroy M, Boe ¨lle P-Y,
Watier L, Guillemot D (2009) Signif-
icant reduction of antibiotic use in
the community after a nationwide
campaign in France, 2002–2007.
PLoS Med 6(6): e1000084. doi:10.
1371/journal.pmed.1000084
Didier Guillemot and colleagues
describe the evaluation of a nation-
wide programme in France aimed
at decreasing unnecessary outpa-
tient prescriptions for antibiotics.
The campaign was successful, par-
ticularly in reducing prescriptions
for children.
PLoS Medicine | www.plosmedicine.org 1 June 2009 | Volume 6 | Issue 6 | e1000080otic use was also seen without major
campaigns. The paper does not provide
any information about surrogate markers
that might explain the campaign’s success,
such as the public’s awareness of the
campaign or changes in knowledge and
attitudes among physicians and the public.
A limitation inherent to any multifaceted,
complex intervention is that no clue is
provided to identify which of the numer-
ous interventions were most effective and
could be recommended to other countries.
Finally, although the impact on antibiotic
prescriptions is impressive, the effect on
antimicrobial resistance is still unclear and
difficult to separate from the effect of the
conjugate pneumococcal vaccine [11,12].
Cost Issues
Guillemot and colleagues report that
developing and conducting the campaign
cost 500 million euros over six years,
which seems extremely costly considering
that the Belgian campaign cost only about
400,000 euros per year [7]. But without
more detailed cost-benefit analyses, this
cost information should be interpreted
with caution. It is, however, noteworthy
that the reduction in antibiotic costs in
France outweighed the cost of the public
campaign to reduce prescribing.
The amount of money spent by the
pharmaceutical industry to promote antibi-
otics should also be considered when assess-
ingcostissues.Unfortunately,wedonothave
access to these figures for Europe. However,
intheUnitedStatesin1998,itwasestimated
that pharmaceutical companies spent about
US$1.6 billion to promote antibiotics, an
amount that vastly exceeds any budget
allocated to antibiotic campaigns [13].
Is the French Experience an
Example for Other Countries To
Follow?
Overall, the results of the French public
campaign are very encouraging and con-
firm those of the Belgian campaign: in
countries with high baseline antibiotic use,
sustained and multifaceted campaigns
using mass media as well as targeting
physicians can decrease antibiotic use
substantially. Nonetheless, given the vari-
ations in antibiotic usage patterns, socio-
cultural determinants, and health care
systems, different approaches are warrant-
ed for different countries [3]. Future
campaign managers are certainly well-
advised to apply social marketing concepts
to identify the optimal approach for their
own country [14]. We should not forget,
however, that some national campaigns
(e.g., Greece, Spain, England, Australia)
failed to show a major impact on antibiotic
prescriptions, although few of these data
have been published [15,16]. On the other
hand, Sweden succeeded in reducing
antibiotic use by a comprehensive pro-
gram without a public campaign compo-
nent [17].
Next Steps
Since the ultimate goal of any campaign
to reduce antibiotic use is to curb antibi-
otic resistance, more longitudinal and
modeling studies are needed. Realistically,
these studies may require individual pa-
tient data from small-scale surveillance
networks, including monitoring of poten-
tial adverse effects of reduced prescribing.
All in all, the French have to be
congratulated for their success story dem-
onstrating that, if policy makers and
opinion leaders are serious about reducing
antibiotic misuse, this goal can be achieved
by well-coordinated national efforts.
Throughout the world, we should no
longer accept antibiotic misuse and resis-
tance as ‘‘automatic’’.
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